Class II · Moderate riskTerminated Initiated Jul 16, 2019 (7 years ago)
Temozolomide Capsules, 100 mg, packaged in a) 5-count bottle (NDC 67877-539-07), b)…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.
What was recalled
Temozolomide Capsules, 100 mg, packaged in a) 5-count bottle (NDC 67877-539-07), b) 14-count bottle (NDC 67877-539-14), Rx only, Manufactured by: Deva Holding A.S., 1 Merkez Mahallesi, Istanbul, Turkey 34303, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.
Recalling firm
Deva Holding AS - Cerkezkoy Subesi
NDC code
67877-539-07
Origin
N/A, Turkey
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1510-2019
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.